The U.S. Food and Drug Administration is investigating whether certain cancer treatments can increase risk for secondary cancers, according to CNN Health. The agency has received 19 reports of T-cell malignancies among people who were previously treated with certain chimeric antigen receptor T-cell (CAR-T) therapies. The FDA approved the first CAR-T cancer therapy in 2017, and required 15-year follow-up studies to asses long-term safety.
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
